Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

brexit_flag

83% in healthcare say UK will not be attractive for R&D and manufacturing post-Brexit

November 30, 2018 Medical Communications, Research and Development R&D, UK, brexit, pharma

As the Brexit crisis continues to spiral, new findings from GlobalData reveal that 83% of healthcare professionals in the UK …
News
genentech_web

Roche’s Genentech to acquire inflammatory drug discovery firm Jecure

November 28, 2018 Research and Development, Sales and Marketing Genentech, Jecure, Roche, liver disease, nash, pharma

Roche’s subsidiary Genentech has finalised a definitive agreement to acquire Jecure, a US-based biotech which focuses on the discovery of …
News
shutterstock_204190579

UK cervical cancer screening rates fall to 21-year low

November 28, 2018 Medical Communications, Research and Development Cancer, NHS, UK, cervical cancer, pharma

A report by NHS Digital has revealed that cervical cancer screening coverage has fallen to 71.4%, down from 72% in …
News
epipen

Teva’s EpiPen generic retails for same price as Mylan’s own

November 28, 2018 Research and Development, Sales and Marketing Mylan, Teva, epipen, pharma

Israeli generics firm Teva has revealed the price tag of its generic version of Mylan’s EpiPen epinephrine auto-injector, and, at …
News
bayercross3

Bayer’s Jivi approved in Europe for previously treated haemophilia A

November 28, 2018 Research and Development, Sales and Marketing Bayer, Jivi, haemophilia, pharma

Bayer has revealed that its recombinant Factor VIII (rFVIII) replacement therapy Jivi, also known as BAY94-9027, has received approval from …
News
takeda_usa_pharmaceuticals_u

European approval for Takeda’s Alunbrig in ALK+ advanced non-small cell lung cancer

November 27, 2018 Research and Development, Sales and Marketing Alunbrig, Cancer, Takeda, lung cancer, pharma

Takeda’s Alunbrig (brigatinib) has been granted marketing approval by the European Commission as a monotherapy to treat anaplastic lymphoma kinase-positive …
News
stocks1

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

November 27, 2018 Manufacturing and Production, Research and Development asthma, pharma, trial failure, vectura

Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, …
News
bmssyracuseny

BMS’ Opdivo+Yervoy combo fails in small cell lung cancer

November 27, 2018 Manufacturing and Production, Research and Development Bristol-Myers Squibb, Cancer, Yervoy, lung cancer, opdivo, pharma

Bristol-Myers Squibb has revealed that its combo comprising Opdivo (nivolumab) and Yervoy (ipilimumab) failed to meet its primary endpoint as …
News
novo_nordisk_flag

Novo Nordisk’s semaglutide meets primary endpoint of reducing cardiovascular events at Phase 3

November 26, 2018 Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide

Novo Nordisk has revealed new Phase 3a data for its investigational GLP-1 analogue therapy semaglutide, showing that the drug met …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kymriah, Mundipharma, UK, US, brexit, pharma, politics, top 10

The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …
News

Pfizer’s Daurismo becomes first of its kind to secure FDA approval in acute myeloid leukaemia

November 22, 2018 Research and Development, Sales and Marketing AML, Daurismo, FDA, Pfizer, US, leukaemia

Pfizer has revealed that the FDA has chosen to approve its Daurismo (glasdegib) for the treatment of newly-diagnosed acute myeloid …
News
gsk_china_2_2_0_1

GSK retain top spot on access to medicines list

November 22, 2018 Business Services, Research and Development GSK, J&J, JJ, R&D, Sanofi, access, low and middle income countries, researh

The majority (63%) of research and development projects are being conducted by just five companies; GSK, Johnson & Johnson, Sanofi, …
News

Probiotics have no effect on children with gastroenteritis, study shows

November 22, 2018 Research and Development children, flu, gastroenteritis, probiotics, research

Despite the claims of marketing campaigns and advertisements, probiotics have no effect on gastroenteritis on children, according to a new …
News

FDA approves first ever therapy for ultra rare primary haemophagocytic lymphohistiocytosis

November 21, 2018 Research and Development, Sales and Marketing FDA, Novimmune, pharma, sobi

The partnership of Sobi and Novimmune has revealed that their interferon gamma (IFNγ) blocking antibody Gamifant (emapalumab-lzsg) has received approval …
News

Mylan’s Morgantown plant receives FDA warning letter

November 21, 2018 Research and Development Mylan, pharma

Generic drugmaker Mylan has received a warning letter from the FDA over concerns surrounding the firm’s manufacturing plant in West …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026